March 9, 2020 / 11:13 AM / a month ago

BRIEF-Bioxcel Therapeutics Reports Q4 And Full Year 2019 Financial Results

March 9 (Reuters) - BioXcel Therapeutics Inc:

* BIOXCEL THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* BIOXCEL THERAPEUTICS - KEY BXCL501 DATA READOUTS EXPECTED IN MID 2020 INCLUDING RESULTS FROM SERENITY PROGRAM & PHASE 1B/2 TRANQUILITY TRIAL IN GERIATRIC DEMENTIA

* BIOXCEL THERAPEUTICS - STOCK OFFERING PROCEEDS OF $60 MILLION & CURRENT RESERVES PROVIDE CO CASH RUNWAY TO FUND KEY CLINICAL, REGULATORY & OPERATIONAL MILESTONES INTO 2021

* BIOXCEL THERAPEUTICS INC - REPORTED NET LOSS OF $8.3 MILLION FOR Q4 OF 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below